Here's Why Genetic Testing Stocks Tumbled in September
Most stocks in the industry cooled off from all-time highs. Will they keep sliding?
Genomic Health
GHDX
GHDX
$71.32
$1.56
2.2%
BATS BZX Real Time Price as of October 15, 2019, 4:00 p.m. EDT
View Interactive GHDX Charts
Genomic Health's diagnostic tests offer innovative cancer screening.
News & Analysis: Genomic Health
The Fool has written over 100 articles on Genomic Health.
A Cancer Diagnostics Company You Should Own Today
Since the start of September, the luster has disappeared from Exact Sciences' stock. This pullback provides an opportunity to own a company that is growing on multiple levels.
Genomic Health's Second Quarter Was So Great It Got the Company Acquired
Exact Sciences takes out the cancer-test maker for $2.8 billion.
Here's Why Genetic Testing Stocks Rose as Much as 25.4% in July
It was a great month to be a genetic testing company.
Genomic Health Inc (GHDX) Q2 2019 Earnings Call Transcript
GHDX earnings call for the period ending June 30, 2019.
Why Exact Sciences Is Sinking and Genomic Health Is Rising
Shares are heading in opposite directions after the two cancer diagnostic companies surprised Wall Street by revealing plans to merge. Here's what investors need to know.
Here's Why Genomic Health Jumped Almost 15% Today
It had nothing to do with the underlying value of the company.
3 Stocks to Buy Ahead of the Next Market Crash
Invest for the long term with these three stocks.
Here's Why Genetic Testing Stocks Lost as Much as 26.1% in May
Wall Street soured on the high-growth industry after first-quarter earnings were reported, but it may have been an overreaction for two stocks.
3 Cancer Treatment Stocks to Buy Right Now
These companies could make a big difference in how the disease is diagnosed and treated. And their stocks could make a big difference for long-term investors.
